Heiko Hermeking

15PUBLICATIONS
24CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 15, 2026
Myeloid Mir34a suppresses initiation and progression of intestinal and colitis-induced colon cancers in APCmin mice.

|Apr 21, 2026
TGF-β/SMAD4/14-3-3σ/TFEB axis promotes mesenchymal-epithelial transition and inhibits autophagy in colorectal cancer.

|Feb 13, 2026
RBM47-Induced Gasdermin A/GSDMA Mediates Mesenchymal-Epithelial Transition and Pyroptosis of Colorectal Cancer Cells.

Yuyun Du, Matjaz Rokavec, Heiko Hermeking

|Dec 03, 2025
Down-regulation of RBM47 due to diminished activation by forkhead box A1 (FOXA1) and silencing by CpG methylation is associated with epithelial-mesenchymal transition and metastasis of colorectal cancer.

Matjaz Rokavec, Yuyun Du, Heiko Hermeking

|Oct 18, 2024
Myeloid Mir34a suppresses colitis-associated colon cancer: characterization of mediators by single-cell RNA sequencing.

Janine König, Matjaz Rokavec, Meryem Gülfem Öner-Ziegler

|May 11, 2024
LINC01021 Attenuates Expression and Affects Alternative Splicing of a Subset of p53-Regulated Genes.

Markus Kaller, Ignasi Forné, Axel Imhof

Pageof 3

Frequent Collaborators

3 joint publications

Matjaz Rokavec

2 joint publications

Jens Neumann

2 joint publications

Zekai Huang

2 joint publications

Markus Kaller